GFACX
Price
$73.34
Change
+$0.45 (+0.62%)
Updated
Aug 28 closing price
Net Assets
327.53B
JDCRX
Price
$48.85
Change
+$0.41 (+0.85%)
Updated
Aug 28 closing price
Net Assets
23.92B
Interact to see
Advertisement

GFACX vs JDCRX

Header iconGFACX vs JDCRX Comparison
Open Charts GFACX vs JDCRXBanner chart's image
American Funds Growth Fund of Amer C
Price$73.34
Change+$0.45 (+0.62%)
VolumeN/A
Net Assets327.53B
Janus Henderson Forty R
Price$48.85
Change+$0.41 (+0.85%)
VolumeN/A
Net Assets23.92B
GFACX vs JDCRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. JDCRX commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Buy and JDCRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 328B vs. JDCRX (23.9B). GFACX (0.00) and JDCRX (0.00) have matching dividends . GFACX was incepted earlier than JDCRX: GFACX (24 years) vs JDCRX (21 years). GFACX (1.36) is less costly to investors than JDCRX (1.27). JDCRX is a more actively managed with annual turnover of: 36.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than JDCRX: GFACX (250) vs JDCRX (2500). GFACX annual gain was more profitable for investors over the last year : 13.55 vs. JDCRX (7.36). GFACX return over 5 years is better than : 28.67 vs. JDCRX (13.87).
GFACXJDCRXGFACX / JDCRX
Total Expense Ratio1.361.27107%
Annual Report Gross Expense Ratio1.361.27107%
Fund Existence24 years21 years-
Gain YTD15.02514.322105%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets328B23.9B1,372%
Annual Yield % from dividends0.000.00-
Returns for 1 year13.557.36184%
Returns for 3 years47.9551.6693%
Returns for 5 years28.6713.87207%
Returns for 10 years79.7562.45128%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PPBT2.270.05
+2.25%
Purple Biotech Ltd
CELU3.850.05
+1.32%
Celularity
PTLO7.090.09
+1.29%
Portillo's
CF87.310.96
+1.11%
CF Industries Holding
NBTB44.76-0.31
-0.69%
NBT Bancorp